Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To assess the impact of adding statin (atorvastatin) and/or aspirin on clinical deterioration in patients infected with SARS-CoV-2 who require hospitalisation. The safety of these drugs in COVID-19 patients will also be evaluated. TRIAL DESIGN: This is a single-centre, prospective, four-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghati, Nirmal, Roy, Ambuj, Bhatnagar, Sushma, Bhati, Sumit, Bhushan, Sudha, Mahendran, Manjit, Thakur, Abhishek, Tiwari, Pawan, Dwivedi, Tanima, Mani, Kalaivani, Gupta, Ritu, Mohan, Anant, Garg, Rakesh, Saxena, Anita, Guleria, Randeep, Deepti, Siddharthan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598224/
https://www.ncbi.nlm.nih.gov/pubmed/33126910
http://dx.doi.org/10.1186/s13063-020-04840-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598224/
https://www.ncbi.nlm.nih.gov/pubmed/33126910
http://dx.doi.org/10.1186/s13063-020-04840-y

Ejemplares similares